A method of treating an individual having a viral infection or long hauler syndrome, the method comprising the steps of: providing an individual having a viral infection; and administering eight antivirals to the individual, wherein the antivirals comprise: hydroxychloroquine, azithromycin or doxycycline, ivermectin, oseltamivir phosphate, vitamin c, vitamin d, zinc, and bifidobacterial probiotics. Optionally, the method can also comprise administering famotidine, aspirin, cyproheptadine, a budesonide inhaler, and an iodine nasal spray. A combination of two or more antivirals for treating a viral infection or long hauler syndrome, the combination comprising at least two of the following: hydroxychloroquine, azithromycin or doxycycline, ivermectin, oseltamivir phosphate, famotidine, vitamin c, vitamin d, zinc, aspirin, bifidobacterial probiotics, cyproheptadine, budesonide inhaler, and iodine nasal spray.

A method of treating an individual having a viral infection or long hauler syndrome, the method comprising the steps of: providing an individual having a viral infection; and administering eight antivirals to the individual, wherein the antivirals comprise: hydroxychloroquine, azithromycin or doxycycline, ivermectin, oseltamivir phosphate, vitamin c, vitamin d, zinc, and bifidobacterial probiotics. Optionally, the method can also comprise administering famotidine, aspirin, cyproheptadine, a budesonide inhaler, and an iodine nasal spray. A combination of two or more antivirals for treating a viral infection or long hauler syndrome, the combination comprising at least two of the following: hydroxychloroquine, azithromycin or doxycycline, ivermectin, oseltamivir phosphate, famotidine, vitamin c, vitamin d, zinc, aspirin, bifidobacterial probiotics, cyproheptadine, budesonide inhaler, and iodine nasal spray.

The disclosure provides a semi-solid composition, comprising a gelling component in a sufficient amount to provide a cohesive gelled product, an anti-histamine composition, comprising an antihistamine, and a complexing agent, wherein the complexing agent is capable of interacting with the antihistamine and forming an antihistamine complex. In one embodiment, the antihistamine comprises diphenhydramine, cetirizine, levocetirizine, loratadine, desloratadine, fexofenadine, azelastine, bilastine, rupatadine, or a derivative, salt or a combination thereof.

The disclosure provides a semi-solid composition, comprising a gelling component in a sufficient amount to provide a cohesive gelled product, an anti-histamine composition, comprising an antihistamine, and a complexing agent, wherein the complexing agent is capable of interacting with the antihistamine and forming an antihistamine complex. In one embodiment, the antihistamine comprises diphenhydramine, cetirizine, levocetirizine, loratadine, desloratadine, fexofenadine, azelastine, bilastine, rupatadine, or a derivative, salt or a combination thereof.

The compositions of the present invention comprise at least one medium polarity oil and at least one antibacterial agent, the combination of which produces a synergistic antibacterial effect against bacterial biofilms. Methods are disclosed for the reduction of bacteria in and/or elimination of bacterial biofilms on biological and non-biological surfaces, as well as methods for the treatment of wounds, skin lesions, mucous membrane lesions, and other biological surfaces infected or contaminated with bacterial biofilms.

The compositions of the present invention comprise at least one medium polarity oil and at least one antibacterial agent, the combination of which produces a synergistic antibacterial effect against bacterial biofilms. Methods are disclosed for the reduction of bacteria in and/or elimination of bacterial biofilms on biological and non-biological surfaces, as well as methods for the treatment of wounds, skin lesions, mucous membrane lesions, and other biological surfaces infected or contaminated with bacterial biofilms.

The compositions of the present invention comprise at least one medium polarity oil and at least one antibacterial agent, the combination of which produces a synergistic antibacterial effect against bacterial biofilms. Methods are disclosed for the reduction of bacteria in and/or elimination of bacterial biofilms on biological and non-biological surfaces, as well as methods for the treatment of wounds, skin lesions, mucous membrane lesions, and other biological surfaces infected or contaminated with bacterial biofilms.

The application provides nutraceutical compositions supporting an active life style and helps with the post-exercise recover. In one embodiment, the nutraceutical composition includes a gelling component in a sufficient amount to provide a cohesive gelled product and an active component. The active component consists of a vitamin B composition, a carbohydrate composition, an amino acid composition, an antioxidant composition, and an anti-inflammatory.

The application provides nutraceutical compositions supporting an active life style and helps with the post-exercise recover. In one embodiment, the nutraceutical composition includes a gelling component in a sufficient amount to provide a cohesive gelled product and an active component. The active component consists of a vitamin B composition, a carbohydrate composition, an amino acid composition, an antioxidant composition, and an anti-inflammatory.

A method of improving microbiome within an animal can comprise administering to the animal a composition comprising a probiotic and psyllium, wherein the probiotic comprises at least one of any suitable strain or subspecies of Enterococcus. Compositions containing a probiotic and psyllium are also provided herein.